FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17468211000001102: Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60386501000001111 Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60386601000001110 Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 3 (CD No Register) true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Is a Buprenorphine 52.5micrograms/hour transdermal patch false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Buprenorphine true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Is a Transtec true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Is a Buprenorphine 52.5micrograms/hour transdermal patches false Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Is a Buprenorphine 52.5micrograms/hour transdermal patches true Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has AMP True Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 3 patch Has AMP True Transtec 52.5micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start